Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1-2 PK/PD study of pegylated human G-CSF versus rhG-CSF in chemotherapy-induced neutropenia
ChiCTR-TRC-12002499Phase 2Completed
- Sponsor
- Beijing Chest Hospital
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of pegfilgrastim and filgrastim in chemotherapy-induced neutropenia (CIN) (4 arms), sponsored by Beijing Chest Hospital. Primary endpoint: Blood drug concentration. Started Oct 2010; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on ChiCTR-TRC-12002499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002499.